EN
登录

角膜基质来源的间充质基质细胞的替代性冷冻保护剂的临床应用

Alternative cryoprotective agent for corneal stroma-derived mesenchymal stromal cells for clinical applications

Nature 等信源发布 2024-07-09 02:57

可切换为仅中文


AbstractCryopreservation of human corneal stroma-derived mesenchymal stromal cells (hCS-MSCs) with dimethylsulfoxide (DMSO) as a cryoprotective agent (CPA) has not been previously compared to that with glycerol under standard conditions. The hCS-MSCs were hereby cryopreserved with both compounds using a freezing rate of 1 °C/minute.

摘要在标准条件下,用二甲基亚砜(DMSO)作为冷冻保护剂(CPA)冷冻保存人角膜基质来源的间充质基质细胞(hCS-MSCs)之前尚未与甘油进行比较。因此,使用1℃/分钟的冷冻速率将hCS-MSC与两种化合物一起冷冻保存。

The CPAs were tested by different concentrations in complete Minimum Essential Medium (MEM) approved for good manufacturing practice, and a medium frequently used in cell laboratory culturing—Dulbecco’s modified eagle serum. The hCS-MSCs were isolated from cadaveric human corneas obtained from the Norwegian Eye Bank, and immunophenotypically characterized by flow cytometry before and after cryopreservation.

CPA在批准用于良好生产规范的完全最低必需培养基(MEM)和细胞实验室培养Dulbecco改良eagle血清中经常使用的培养基中以不同浓度进行测试。从挪威眼库获得的尸体角膜中分离hCS-MSCs,并在冷冻保存前后通过流式细胞术进行免疫表型表征。

The survival rate, the cellular adhesion, proliferation and cell surface coverage after cryopreservation of hCS-MSCs has been studied. The hCS-MSCs were immunofluorescent stained and examined for their morphology microscopically. The results showed that cryopreservation of hCS-MSCs in MEM with 10% glycerol gives a higher proliferation rate compared to other cryopreserving media tested.

研究了hCS-MSCs冷冻保存后的存活率,细胞粘附,增殖和细胞表面覆盖率。对hCS-MSC进行免疫荧光染色并在显微镜下检查其形态。结果表明,与其他测试的冷冻保存介质相比,在含有10%甘油的MEM中冷冻保存hCS-MSCs具有更高的增殖率。

Based on the results, hCS-MSCs can safely be cryopreserved using glycerol instead of the traditional use of DMSO..

根据结果,hCS-MSCs可以使用甘油而不是传统的DMSO进行冷冻保存。。

IntroductionIn developing countries in Asia and Africa, corneal diseases requiring transplantation often stem from infectious and nutritional issues, while developed countries face inherited degenerative corneal disorders like keratoconus and Fuchs` corneal endothelial dystrophy that may require corneal transplantation or keratoplasty1,2, which is limited by donor scarcity and pre- and post- operative complications2.

引言在亚洲和非洲的发展中国家,需要移植的角膜疾病通常源于感染和营养问题,而发达国家则面临遗传性退行性角膜疾病,如圆锥角膜和Fuchs角膜内皮营养不良,可能需要角膜移植或角膜成形术1,2,这受到供体稀缺和手术前后并发症的限制2。

Taking this into consideration and the millions of patients waiting to be treated for corneal diseases, there is a need for alternatives using regenerative medicine technologies3,4,5.Researchers are exploring cell-based therapy in different medical fields, including ocular diseases3,4,5. To succeed with such therapy, there are certain required traits for the specific cell lines6.

考虑到这一点以及数百万等待治疗角膜疾病的患者,需要使用再生医学技术替代3,4,5。研究人员正在探索不同医学领域的细胞疗法,包括眼部疾病3,4,5。为了成功进行这种治疗,特定细胞系有某些必需的特征6。

Mesenchymal stromal/stem cells (MSCs) have been shown to possess several unique properties (e.g. multilineage differentiation potential, induction of tissue repairment, immunomodulation) for cell-based therapy6. Since 2005, some authors including our group have studied the multipotency of human corneal stroma-derived MSCs (hCS-MSCs)7,8,9,10,11.

间充质基质/干细胞(MSCs)已被证明具有几种独特的特性(例如多向分化潜能,组织修复诱导,免疫调节)用于基于细胞的治疗6。。

These cells are abundant in the central part of the corneal stroma and possess ability to reduce corneal scarring in a mouse model7,10,11, as well as wound healing properties in vitro7.Challenges such as the lack of suitable preservation conditions in good manufacturing practices (GMP) persist12,13.

这些细胞在角膜基质的中央部分丰富,并且具有减少小鼠模型中角膜瘢痕形成的能力7,10,11,以及体外伤口愈合特性7。诸如在良好生产规范(GMP)中缺乏合适的保存条件等挑战持续存在12,13。

Many authors employed basal growth media containing multiple nutrients, growth factors, and fetal bovine serum (FBS), which has been the gold standard medium supplement in many laboratories throughout the world12. However, the FBS can potentially represent a source of zoonotic infections and xenogenic antigens, both of which can impair the cell c.

许多作者使用含有多种营养素,生长因子和胎牛血清(FBS)的基础生长培养基,这是世界各地许多实验室的金标准培养基补充剂12。然而,FBS可能代表人畜共患感染和异种抗原的来源,这两者都可能损害细胞c。

Table 1 Different cell culturing media and cryoprotective agents (CPAs) used in the experiments.Full size tableThree primary hCS-MSCs donors were counted with a Bürker chamber using Tryphan Blue to visualize the live cells and, subsequently, approximately 7.5·105–1·106 cells/mL were cryopreserved in media containing DMSO or glycerol.

表1实验中使用的不同细胞培养基和冷冻保护剂(CPA)。全尺寸表使用台盼蓝用Bürker室对三个原代hCS-MSCs供体进行计数,以可视化活细胞,随后将约7.5·105-1·106个细胞/mL冷冻保存在含有DMSO或甘油的培养基中。

The hCS-MSCs cryopreserved in DMSO were gently mixed and immediately transferred into − 80 °C inside a freezing container (Mr. Frosty; 1 °C/min cooling rate), while the hCS-MSCs cryopreserved with glycerol were gently mixed in the cryovial and left on the bench for 20 min prior to transferring into − 80 °C inside the Mr.

将在DMSO中冷冻保存的hCS-MSCs轻轻混合,并立即转移到冷冻容器内的-80°C(Frosty先生;1°C/min冷却速率),而将用甘油冷冻保存的hCS-MSCs轻轻混合在冷冻瓶中并在台上放置20分钟,然后转移到Mr内的-80°C。

Frosty. All the cryovials were transferred after a few days into liquid nitrogen for at least two weeks storage.Cell surface marker phenotype characterization of the hCS-MSCsThe immunophenotype characterization of the hCS-MSCs was carried out using a BD Accuri™ C6 personal flow cytometer (Becton Dickinson, NJ, USA).

霜冻。几天后,将所有冷冻瓶转移到液氮中保存至少两周。hCS-MSC的细胞表面标记表型表征使用BD Accuri™C6个人流式细胞仪(Becton Dickinson,NJ,USA)进行hCS-MSC的免疫表型表征。

FITC, PE and APC- conjugated antibodies (Biolegend, CA, USA) were obtained, against cell surface- expressed proteins: CD31, CD34, CD44, CD45, CD73, CD90, CD105, CD106, CD117, CD146, CD166, CD184 (Sup. Table 1).Briefly, 1·105 dissociated cells were pipetted into individual 1.5 mL tubes (Corning® Axygen®, Merck/Sigma-Aldrich, MO, USA), rinsed and pelleted in cold fluorescence-activated cell sorting (FACS) buffer (0.5% bovine serum albumin (Thermo Fisher Scientific, MA, USA) in DPBS (1X)).

获得了针对细胞表面表达蛋白的FITC,PE和APC偶联抗体(Biolegend,CA,USA):CD31,CD34,CD44,CD45,CD73,CD90,CD105,CD106,CD117,CD146,CD166,CD184(表1)。简而言之,将1.105个解离的细胞移液到单独的1.5 mL管(Corning®Axygen®,Merck/Sigma-Aldrich,MO,USA)中,在冷荧光激活细胞分选(FACS)缓冲液(0.5%牛血清白蛋白(Thermo Fisher Scientific,MA,USA)中冲洗并沉淀在DPBS(1X)中)。

Antibody solutions (1:40) were added to the individual tubes with the cells, gently resuspended and incubated on ice for 30 min. Once completed, the hCS-MSCs were washed twice in cold FACS buffer, centrifuged (3 min, 500 RCF g, 4 °C) then resuspended in 0.2 mL buffer before measurement. The immunophenotype characterization was pe.

将抗体溶液(1:40)与细胞一起加入到各个试管中,轻轻重悬并在冰上孵育30分钟。完成后,将hCS-MSC在冷FACS缓冲液中洗涤两次,离心(3分钟,500 RCF g,4°C),然后在测量前重悬于0.2 mL缓冲液中。。

Data availability

数据可用性

The original contributions presented in the study are included in the article/Supplementary Material; further inquiries can be directed to the corresponding author.

研究中提出的原始贡献包含在文章/补充材料中;进一步的询问可以直接联系通讯作者。

ReferencesGlobal initiative for the elimination of avoidable blindness [Internet]. [cited 2023 Jan 19]. https://apps.who.int/iris/handle/10665/63748.Donald, D. et al. Ophthalmology 3 Corneal transplantation. Lancet 379, 1749–1761 (2012).Article

参考消除可避免失明全球倡议[互联网]。[引自2023年1月19日]。https://apps.who.int/iris/handle/10665/63748.Donald,D.等人,《眼科学3角膜移植》。。文章

Google Scholar

谷歌学者

Hoang, D. M. et al. Stem cell-based therapy for human diseases. Signal Transduct. Target. Ther. 7, 1–41 (2022).

Hoang,D.M.等人。基于干细胞的人类疾病治疗。信号传输管。目标。他们。7,1-41(2022)。

Google Scholar

谷歌学者

Eveleth, D. D. Cell-based therapies for ocular disease. J. Ocul. Pharmacol. Ther. 29, 844–54 (2013).Article

Eveleth,D.D。基于细胞的眼部疾病治疗。J、 眼科。药理学。他们。29844-54(2013)。文章

CAS

中科院

PubMed

PubMed

Google Scholar

谷歌学者

Proulx, S., Fradette, J., Gauvin, R., Larouche, D. & Germain, L. Stem cells of the skin and cornea: Their clinical applications in regenerative medicine. Curr. Opin. Organ. Transplant. 16(1), 83–89 (2011).Article

Proulx,S.,Fradette,J.,Gauvin,R.,Larouche,D。和Germain,L。皮肤和角膜干细胞:它们在再生医学中的临床应用。。奥平。器官。移植。16(1),83-89(2011)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Zhang, J. et al. The challenges and promises of allogeneic mesenchymal stem cells for use as a cell-based therapy. Stem Cell Res. Ther. https://doi.org/10.1186/s13287-015-0240-9 (2015).Article

Zhang,J.等人。同种异体间充质干细胞作为基于细胞的疗法的挑战和前景。干细胞研究。https://doi.org/10.1186/s13287-015-0240-9(2015年)。文章

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Veréb, Z. et al. Role of human corneal stroma-derived mesenchymal-like stem cells in corneal immunity and wound healing. Sci. Rep. https://doi.org/10.1038/srep26227 (2016).Article

Veréb,Z.等人。人角膜基质来源的间充质样干细胞在角膜免疫和伤口愈合中的作用。科学。代表。https://doi.org/10.1038/srep26227(2016年)。文章

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Du, Y., Funderburgh, M. L., Mann, M. M., Sundar Raj, N. & Funderburgh, J. L. Multipotent stem cells in human corneal stroma. Stem Cells 23(9), 1266–75 (2005).Article

Du,Y.,Funderburgh,M.L.,Mann,M.M.,Sundar Raj,N。&Funderburgh,J.L。人角膜基质中的多能干细胞。干细胞23(9),1266-75(2005)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Du, Y. et al. Secretion and organization of a cornea-like tissue in vitro by stem cells from human corneal stroma. Investig. Ophthalmol. Vis. Sci. 48(11), 5038–45 (2007).Article

Du,Y.等人。人角膜基质干细胞在体外分泌和组织角膜样组织。调查。眼科。可见。科学。48(11),5038–45(2007)。文章

Google Scholar

谷歌学者

Basu, S. et al. Human limbal biopsy-derived stromal stem cells prevent corneal scarring. Sci. Transl. Med. https://doi.org/10.1126/scitranslmed.3009644 (2014).Article

Basu,S.等人。人角膜缘活检来源的基质干细胞预防角膜瘢痕形成。科学。翻译。医学。https://doi.org/10.1126/scitranslmed.3009644(2014年)。文章

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Du, Y. et al. Stem cell therapy restores transparency to defective murine corneas. Stem Cells 27(7), 1635–1642 (2009).Article

Du,Y.等人。干细胞疗法恢复了缺陷小鼠角膜的透明度。干细胞27(7),1635-1642(2009)。文章

CAS

中科院

PubMed

PubMed

Google Scholar

谷歌学者

Becherucci, V. et al. Human platelet lysate in mesenchymal stromal cell expansion according to a GMP grade protocol: A cell factory experience. Stem Cell Res. Ther. https://doi.org/10.1186/s13287-018-0863-8 (2018).Article

Becherucci,V。等人。根据GMP级方案,间充质基质细胞扩增中的人血小板裂解物:细胞工厂经验。干细胞研究。https://doi.org/10.1186/s13287-018-0863-8(2018年)。文章

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

CHMP, CPWP. GUIDELINE ON HUMAN CELL-BASED MEDICINAL PRODUCTS [Internet]. http://www.emea.europa.eu. (2006).Note for guidance on minimising the risk of transmitting animal spongiform encephalopathy agents via human and veterinary medicinal products (EMA/410/01 rev.3) [Internet]. www.ema.europa.eu.Schallmoser, K.

CHMP,CPWP。基于人体细胞的医药产品指南[互联网]。http://www.emea.europa.eu.(2006年)。关于尽可能降低通过人类和兽药产品传播动物海绵状脑病药物的风险的指导说明(EMA/410/01 rev.3)[互联网]。www.ema.europa.eu。沙尔莫斯,K。

et al. Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion (Paris) 47(8), 1436–1446 (2007).Article .

人血小板裂解物可以替代胎牛血清用于功能性间充质基质细胞的临床规模扩增。输血(巴黎)47(8),1436-1446(2007)。文章。

CAS

中科院

Google Scholar

谷歌学者

Burnouf, T., Strunk, D., Koh, M. B. C. & Schallmoser, K. Human platelet lysate: Replacing fetal bovine serum as a gold standard for human cell propagation?. Biomaterials 76, 371–87 (2016).Article

Burnouf,T.,Strunk,D.,Koh,M.B.C。&Schallmoser,K。人血小板裂解物:替代胎牛血清作为人类细胞繁殖的金标准?。生物材料76371-87(2016)。文章

CAS

中科院

PubMed

PubMed

Google Scholar

谷歌学者

Mareschi, K. et al. A new human platelet lysate for mesenchymal stem cell production compliant with good manufacturing practice conditions. Int. J. Mol. Sci. 23(6), 3234 (2022).Article

Mareschi,K。等人。一种用于间充质干细胞生产的新型人血小板裂解物,符合良好生产规范条件。Int.J.Mol.Sci。23(6),3234(2022)。文章

CAS

中科院

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Crook JM, Ludwig TE. Stem Cell Banking Concepts and Protocols Methods in Molecular Biology 1590 [Internet]. http://www.springer.com/series/7651.Murray, K. A. & Gibson, M. I. Chemical approaches to cryopreservation. Nat. Rev. Chem. 6, 579–93 (2022).Article

克鲁克JM,路德维希TE。分子生物学中的干细胞库概念和协议方法1590[互联网]。http://www.springer.com/series/7651.Murray,K.A。&Gibson,M.I。冷冻保存的化学方法。自然化学修订版。6579-93(2022)。文章

CAS

中科院

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Whaley, D. et al. Cryopreservation: An Overview of Principles and Cell-Specific Considerations Vol. 30 (SAGE Publications Ltd, 2021).

Whaley,D.等人,《冷冻保存:原理和细胞特异性考虑概述》,第30卷(SAGE Publications Ltd,2021)。

Google Scholar

谷歌学者

Pacey, A. A. & Tomlinson, M. J. Sperm Banking: Theory and Practice 128 (Cambridge University Press, 2009).Book

Pacey,A.A.&Tomlinson,M.J。精子库:理论与实践128(剑桥大学出版社,2009)。书籍

Google Scholar

谷歌学者

Wolkers WF. Cryopreservation and Freeze-Drying Protocols [Internet]. http://www.springer.com/series/7651.Hunt, C. J. Cryopreservation of human stem cells for clinical application: A review. Transfus. Med. Hemother. 38, 107–23 (2011).Article

Wolkers WF。冷冻保存和冷冻干燥协议[互联网]。http://www.springer.com/series/7651.Hunt,C.J。用于临床应用的人类干细胞冷冻保存:综述。Transfus。医学Hemother。38107-23(2011)。文章

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Verheijen, M. et al. DMSO induces drastic changes in human cellular processes and epigenetic landscape in vitro. Sci. Rep. https://doi.org/10.1038/s41598-019-40660-0 (2019).Article

Verheijen,M。等人。DMSO在体外诱导人类细胞过程和表观遗传景观的剧烈变化。科学。代表。https://doi.org/10.1038/s41598-019-40660-0(2019年)。文章

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Morris, G. J., Goodrich, M., Acton, E. & Fonseca, F. The high viscosity encountered during freezing in glycerol solutions: Effects on cryopreservation. Cryobiology 52(3), 323–334 (2006).Article

Morris,G.J.,Goodrich,M.,Acton,E。&Fonseca,F。在甘油溶液中冷冻期间遇到的高粘度:对冷冻保存的影响。低温生物学52(3),323-334(2006)。文章

CAS

中科院

PubMed

PubMed

Google Scholar

谷歌学者

Grein, T. A. et al. Alternatives to dimethylsulfoxide for serum-free cryopreservation of human mesenchymal stem cells. Sage J. https://doi.org/10.1177/039139881003300605 (2010).Article

Grein,T.A.等人。用于人间充质干细胞无血清冷冻保存的二甲基亚砜替代品。Sage J。https://doi.org/10.1177/039139881003300605(2010年)。文章

Google Scholar

谷歌学者

Gao D, Critser AK. Mechanisms of Cryoinjury in Living Cells [Internet]. https://academic.oup.com/ilarjournal/article/41/4/187/716700.Dominici, M. et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.

高D,克里特AK。活细胞冷冻损伤的机制[互联网]。https://academic.oup.com/ilarjournal/article/41/4/187/716700.Dominici,M.等人。定义多能间充质基质细胞的最低标准。国际细胞治疗学会立场声明。

Cytotherapy 8(4), 315–7 (2006).Article .

细胞疗法8(4),315-7(2006)。文章。

CAS

中科院

PubMed

PubMed

Google Scholar

谷歌学者

Horwitz, E. M. et al. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 7(5), 393–395 (2005).Article

Horwitz,E.M.等人。MSC命名的澄清:国际细胞治疗学会立场声明。细胞疗法7(5),393-395(2005)。文章

CAS

中科院

PubMed

PubMed

Google Scholar

谷歌学者

Sidney, L. E., Branch, M. J., Dua, H. S. & Hopkinson, A. Effect of culture medium on propagation and phenotype of corneal stroma-derived stem cells. Cytotherapy 17(12), 1706–1722 (2015).Article

Sidney,L.E.,Branch,M.J.,Dua,H.S。&Hopkinson,A。培养基对角膜基质干细胞增殖和表型的影响。细胞疗法17(12),1706-1722(2015)。文章

CAS

中科院

PubMed

PubMed

Google Scholar

谷歌学者

Potapova, I. A., Brink, P. R., Cohen, I. S. & Doronin, S. V. Culturing of human mesenchymal stem cells as three-dimensional aggregates induces functional expression of CXCR4 that regulates adhesion to endothelial cells. J. Biol. Chem. 283(19), 13100–7 (2008).Article

Potapova,I.A.,Brink,P.R.,Cohen,I.S。&Doronin,S.V。将人间充质干细胞培养为三维聚集体诱导CXCR4的功能性表达,其调节对内皮细胞的粘附。J、 生物。化学。283(19),13100–7(2008)。文章

CAS

中科院

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Zlotnik, A. Chemokines and cancer. Int. J. Cancer 119, 2026–9 (2006).Article

Zlotnik,A。趋化因子和癌症。。文章

CAS

中科院

PubMed

PubMed

Google Scholar

谷歌学者

Mu È ller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, et al. Involvement of chemokine receptors in breast cancer metastasis [Internet]. www.nature.com. (2001).Bianchi, M. E. & Mezzapelle, R. The chemokine receptor CXCR4 in cell proliferation and tissue regeneration. Front. Immunol.

MuÈller A,Homey B,Soto H,Ge N,Catron D,Buchanan ME等。趋化因子受体参与乳腺癌转移[互联网]。www.nature.com(2001年)。Bianchi,M.E。和Mezzapelle,R。趋化因子受体CXCR4在细胞增殖和组织再生中的作用。正面。免疫。

https://doi.org/10.3389/fimmu.2020.02109 (2020).Article .

https://doi.org/10.3389/fimmu.2020.02109(2020).文章

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Pawig, L., Klasen, C., Weber, C., Bernhagen, J. & Noels, H. Diversity and inter-connections in the CXCR4 chemokine receptor/ligand family: Molecular perspectives. Front. Immunol. https://doi.org/10.3389/fimmu.2015.00429 (2015).Article

Pawig,L.,Klasen,C.,Weber,C.,Bernhagen,J。&Noels,H。CXCR4趋化因子受体/配体家族的多样性和相互连接:分子观点。正面。。https://doi.org/10.3389/fimmu.2015.00429(2015年)。文章

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Zhang, T. Y. et al. The combination of trehalose and glycerol: An effective and non-toxic recipe for cryopreservation of human adipose-derived stem cells. Stem Cell Res. Ther. https://doi.org/10.1186/s13287-020-01969-0 (2020).Article

Zhang,T.Y.等人。海藻糖和甘油的组合:一种有效且无毒的人类脂肪干细胞冷冻保存配方。干细胞研究。https://doi.org/10.1186/s13287-020-01969-0(2020年)。文章

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Miyagi-Shiohira, C. et al. Evaluation of serum-free, xeno-free cryopreservation solutions for human adipose-derived mesenchymal stem cells. Cell Med. 9(1–2), 15–20 (2017).Article

Miyagi Shiohira,C.等人。评估人脂肪间充质干细胞的无血清,无异种冷冻保存溶液。细胞医学9(1-2),15-20(2017)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Roy, S., Arora, S., Kumari, P. & Ta, M. A simple and serum-free protocol for cryopreservation of human umbilical cord as source of Wharton’s jelly mesenchymal stem cells. Cryobiology 68(3), 467–472 (2014).Article

Roy,S.,Arora,S.,Kumari,P。&Ta,M。一种简单且无血清的方案,用于冷冻保存人脐带作为沃顿果冻间充质干细胞的来源。低温生物学68(3),467-472(2014)。文章

CAS

中科院

PubMed

PubMed

Google Scholar

谷歌学者

Gurruchaga, H. et al. Cryopreservation of microencapsulated murine mesenchymal stem cells genetically engineered to secrete erythropoietin. Int. J. Pharm. 485(1–2), 15–24 (2015).Article

Gurruchaga,H。等人。微囊化小鼠间充质干细胞的冷冻保存,基因工程改造以分泌促红细胞生成素。《国际药学杂志》485(1-2),15-24(2015)。文章

CAS

中科院

PubMed

PubMed

Google Scholar

谷歌学者

de Lara, J. F. et al. Evaluation of distinct freezing methods and cryoprotectants for human amniotic fluid stem cells cryopreservation. J. Biomed. Biotechnol. 2012, 1–10 (2012).

de Lara,J.F.等人。评估用于人羊水干细胞冷冻保存的不同冷冻方法和冷冻保护剂。J、 生物医学。生物技术。2012年,1-10(2012)。

Google Scholar

谷歌学者

Zhang, P. Q. et al. The effect of glycerol as a cryoprotective agent in the cryopreservation of adipose tissue. Stem Cell Res. Ther. https://doi.org/10.1186/s13287-022-02817-z (2022).Article

Zhang,P.Q.等人。甘油作为冷冻保护剂在脂肪组织冷冻保存中的作用。干细胞研究。https://doi.org/10.1186/s13287-022-02817-z(2022年)。文章

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Kito K, Kagami H, Kobayashi C, Ueda M, Terasaki H. Effects of Cryopreservation on Histology and Viability of Cultured Corneal Epithelial Cell Sheets in Rabbit.Marquez-Curtis, L. A., Janowska-Wieczorek, A., McGann, L. E. & Elliott, J. A. W. Mesenchymal stromal cells derived from various tissues: Biological, clinical and cryopreservation aspects.

Kito K,Kagami H,Kobayashi C,Ueda M,Terasaki H.冷冻保存对兔培养的角膜上皮细胞片的组织学和活力的影响。Marquez-Curtis,L.A.,Janowska-Wieczorek,A.,McGann,L.E.&Elliott,J.A.W。来源于各种组织的间充质基质细胞:生物学,临床和冷冻保存方面。

Cryobiology 71, 181–97 (2015).Article .

低温生物学71181-97(2015)。文章。

CAS

中科院

PubMed

PubMed

Google Scholar

谷歌学者

Antinori, M. et al. Cryotop vitrification of human oocytes results in high survival rate and healthy deliveries. Reprod. Biomed. Online 14(1), 72–79 (2007).Article

Antinori,M。等人。人卵母细胞的Cryotop玻璃化冷冻可导致高存活率和健康分娩。重新编程。生物医学。在线14(1),72-79(2007)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Oishi, K. et al. Cryopreservation of mouse adipose tissue-derived stem/progenitor cells. Cell Transplant. 17, 35–41 (2008).Article

Oishi,K。等人。小鼠脂肪组织来源的干/祖细胞的冷冻保存。细胞移植。。文章

PubMed

PubMed

Google Scholar

谷歌学者

Thirumala, S., Gimble, J. M. & Devireddy, R. V. Evaluation of methylcellulose and dimethyl sulfoxide as the cryoprotectants in a serum-free freezing media for cryopreservation of adipose-derived adult stem cells. Stem Cells Dev. 19(4), 513–22 (2010).Article

Thirumala,S.,Gimble,J.M。&Deviredy,R.V。在无血清冷冻培养基中评估甲基纤维素和二甲基亚砜作为冷冻保护剂,用于冷冻保存脂肪来源的成体干细胞。干细胞开发19(4),513-22(2010)。文章

CAS

中科院

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Lauterboeck, L., Hofmann, N., Mueller, T. & Glasmacher, B. Active control of the nucleation temperature enhances freezing survival of multipotent mesenchymal stromal cells. Cryobiology 71(3), 384–390 (2015).Article

Lauterboeck,L.,Hofmann,N.,Mueller,T。&Glasmacher,B。成核温度的主动控制增强了多能间充质基质细胞的冷冻存活。低温生物学71(3),384-390(2015)。文章

CAS

中科院

PubMed

PubMed

Google Scholar

谷歌学者

Pollock, K. et al. Improved post-thaw function and epigenetic changes in mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions. Stem Cells Dev. 26(11), 828–842 (2017).Article

Pollock,K.等人。使用多组分渗透压溶液冷冻保存的间充质基质细胞的解冻后功能和表观遗传变化得到改善。干细胞开发26(11),828-842(2017)。文章

CAS

中科院

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Sun, Y., dos Santos, A., Balayan, A. & Deng, S. X. Evaluation of cryopreservation media for the preservation of human corneal stromal stem cells. Tissue Eng. C Methods 26(1), 37–43 (2020).Article

Sun,Y.,dos Santos,A.,Balayan,A。&Deng,S.X。用于保存人角膜基质干细胞的冷冻保存介质的评估。组织工程C方法26(1),37-43(2020)。文章

CAS

中科院

Google Scholar

谷歌学者

Doucet, C. et al. Platelet lysates promote mesenchymal stem cell expansion: A safety substitute for animal serum in cell-based therapy applications. J. Cell. Physiol. 205(2), 228–236 (2005).Article

血小板裂解物促进间充质干细胞扩增:在基于细胞的治疗应用中动物血清的安全替代品。J、 细胞。生理学。205(2),228-236(2005)。文章

CAS

中科院

PubMed

PubMed

Google Scholar

谷歌学者

Azouna, N. et al. Phenotypical and functional characteristics of mesenchymal stem cells from bone marrow: Comparison of culture using different media supplemented with human platelet lysate or fetal bovine serum. Stem Cell Res. Ther. https://doi.org/10.1186/scrt97 (2012).Article

Azouna,N。等人。骨髓间充质干细胞的表型和功能特征:使用补充有人血小板裂解物或胎牛血清的不同培养基进行培养的比较。干细胞研究。https://doi.org/10.1186/scrt97。文章

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Carlson, E. C. et al. Altered KSPG expression by keratocytes following corneal injury. Mol. Vis. 9, 615–23 (2003).CAS

Carlson,E.C.等人在角膜损伤后改变了角膜细胞的KSPG表达。分子量。9615-23(2003)。中科院

PubMed

PubMed

Google Scholar

谷歌学者

Jester J v, Petroll WM, Cavanagh HD. Corneal Stromal Wound Healing in Refractive Surgery: the Role of Myo®broblasts.Jester, J. V. et al. Corneal keratocytes: In situ and in vitro organization of cytoskeletal contractile proteins. Investig. Ophthalmol. Vis. Sci. 35, 730–43 (1994).CAS .

杰斯特J v,彼得罗WM,卡瓦纳HD。。Jester,J.V.等人,《角膜角膜细胞:细胞骨架收缩蛋白的原位和体外组织》。调查。眼科。可见。科学。35730-43(1994)。CAS。

Google Scholar

谷歌学者

Zieske, J. D. Extracellular matrix and wound healing. Curr. Opin. Ophthalmol. 12, 237–241 (2001).Article

Zieske,J.D。细胞外基质和伤口愈合。。奥平。眼科。12237-241(2001)。文章

CAS

中科院

PubMed

PubMed

Google Scholar

谷歌学者

Khorshid FA. The Effect of the Medium Viscosity on the Cells Morphology in Reaction of Cells to Topography-I. Conl, Fac. Sci., KAU. (2004).West-Mays, J. A. & Dwivedi, D. J. The keratocyte: Corneal stromal cell with variable repair phenotypes. Int. J. Biochem. Cell Biol. 38, 1625–31 (2006).Article .

Khorshid FA。细胞与地形反应中培养基粘度对细胞形态的影响-I。Conl,Fac。科学。,考。(2004年)。West Mays,J.A。&Dwivedi,D.J。角膜细胞:具有可变修复表型的角膜基质细胞。Int.J.生物化学。细胞生物学。。文章。

CAS

中科院

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Su, T. T. & O’farrell, P. H. Size control: Cell proliferation does not equal growth. Curr. Biol. 8, 687–9 (1998).Article

Su,T.T。&O'farrell,P.H。大小控制:细胞增殖不等于生长。。生物学杂志8687-9(1998)。文章

Google Scholar

谷歌学者

Nagymihaly, R. M., Moe, M. C. & Petrovski, G. Isolation and culture of corneal stromal stem cells. In Methods in Molecular Biology (ed. Ahearne, M.) 1–15 (Humana Press Inc, 2020).

Nagymihaly,R.M.,Moe,M.C。和Petrovski,G。角膜基质干细胞的分离和培养。在《分子生物学方法》(ed.Ahearne,M.)1-15(Humana Press Inc,2020)中。

Google Scholar

谷歌学者

Download referencesAcknowledgementsThe authors are grateful to Hans Christian Aass, Department of Medicine, University of Oslo, Norway, for assistance with flow cytometry. This work was supported by the Norwegian Research Council grant No. E667269 (3D-CORNEA) within the NANO2021 activity.

下载参考文献致谢作者感谢挪威奥斯陆大学医学系的Hans Christian Aass对流式细胞术的帮助。这项工作得到了挪威研究委员会批准号E667269(3D-CORNEA)在NANO2021活动中的支持。

The authors acknowledge also the financial support provided by the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement no. 801133. The Center for Eye Research and participants in this project have received funding from the Norwegian Association of the Blind and Partially Sighted and the Raagholt foundation.Author informationAuthors and AffiliationsCenter for Eye Research and Innovative Diagnostics, Department of Ophthalmology, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, NorwayKristoffer Larsen, Goran Petrovski & Gerard Boix-LemoncheDepartment of Ophthalmology, Oslo University Hospital, Oslo, NorwayGoran PetrovskiSchool of Medicine, University of Split, 21000, Split, CroatiaGoran PetrovskiUKLONetwork, University St.

作者还感谢欧盟地平线2020研究与创新计划根据第801133号玛丽·斯科多夫斯卡·居里赠款协议提供的财政支持。眼科研究中心和该项目的参与者得到了挪威盲人和部分视力协会和拉格霍尔特基金会的资助。作者信息作者和附属机构奥斯陆大学医学院临床医学研究所眼科研究与创新诊断学系,奥斯陆,NorwayKristoffer Larsen,Goran Petrovski&Gerard Boix LemoncheDepartment of Ophthalmology,奥斯陆大学医院,奥斯陆,NorwayGoran PetrovskiSchool of Medicine,University of Split,21000,Split,CroatiaGoran PetrovskiUKLONetwork,University St。

Kliment Ohridski –Bitola, 7000, Bitola, North MacedoniaGoran PetrovskiAuthorsKristoffer LarsenView author publicationsYou can also search for this author in.

Kliment Ohridski–Bitola,7000,Bitola,北马其顿共和国彼得罗夫斯基作家克里斯托弗·拉尔森维(KristoferLarsenview)作者出版物您也可以在中搜索这位作者。

PubMed Google ScholarGoran PetrovskiView author publicationsYou can also search for this author in

PubMed Google ScholarGoran Petrovsiview作者出版物您也可以在

PubMed Google ScholarGerard Boix-LemoncheView author publicationsYou can also search for this author in

PubMed Google ScholarGerard Boix LemoncheView作者出版物您也可以在

PubMed Google ScholarContributionsConceptualization, KL, and GB-L; formal analysis, KL, and GB-L; funding acquisition, GP, and GB-L; investigation, KL, and GB-L; methodology, GB-L; supervision, GB-L; writing—review and editing, KL, GP, and GB-L. All authors contributed to the article and approved the submitted version.Corresponding authorCorrespondence to.

PubMed谷歌学术贡献概念化,KL和GB-L;形式分析,KL和GB-L;资金收购,GP和GB-L;调查,KL和GB-L;方法学,GB-L;监督,GB-L;撰写评论和编辑,KL,GP和GB-L。所有作者都为文章做出了贡献并批准了提交的版本。对应作者对应。

Gerard Boix-Lemonche.Ethics declarations

杰拉德·博伊克斯·莱蒙切。道德宣言

Competing interests

相互竞争的利益

The authors declare no competing interests.

作者声明没有利益冲突。

Additional informationPublisher's noteSpringer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.Supplementary InformationSupplementary Information.Rights and permissions

Additional informationPublisher的noteSpringer Nature在已发布地图和机构隶属关系中的管辖权主张方面保持中立。补充信息补充信息。权限和权限

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

开放获取本文是根据知识共享署名4.0国际许可证授权的,该许可证允许以任何媒体或格式使用,共享,改编,分发和复制,只要您对原始作者和来源给予适当的信任,提供知识共享许可证的链接,并指出是否进行了更改。

The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

本文中的图像或其他第三方材料包含在文章的知识共享许可中,除非在材料的信用额度中另有说明。如果材料未包含在文章的知识共享许可中,并且您的预期用途不受法律法规的许可或超出许可用途,则您需要直接获得版权所有者的许可。

To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/..

要查看此许可证的副本,请访问http://creativecommons.org/licenses/by/4.0/..

Reprints and permissionsAbout this articleCite this articleLarsen, K., Petrovski, G. & Boix-Lemonche, G. Alternative cryoprotective agent for corneal stroma-derived mesenchymal stromal cells for clinical applications.

转载和许可本文引用本文Larsen,K.,Petrovski,G。&Boix-Lemonche,G。用于临床应用的角膜基质衍生的间充质基质细胞的替代冷冻保护剂。

Sci Rep 14, 15788 (2024). https://doi.org/10.1038/s41598-024-65469-4Download citationReceived: 22 December 2023Accepted: 20 June 2024Published: 09 July 2024DOI: https://doi.org/10.1038/s41598-024-65469-4Share this articleAnyone you share the following link with will be able to read this content:Get shareable linkSorry, a shareable link is not currently available for this article.Copy to clipboard.

Sci Rep 1415788(2024)。https://doi.org/10.1038/s41598-024-65469-4Download引文接收日期:2023年12月22日接收日期:2024年6月20日发布日期:2024年7月9日OI:https://doi.org/10.1038/s41598-024-65469-4Share本文与您共享以下链接的任何人都可以阅读此内容:获取可共享链接对不起,本文目前没有可共享的链接。复制到剪贴板。

Provided by the Springer Nature SharedIt content-sharing initiative

由Springer Nature SharedIt内容共享计划提供

CommentsBy submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

评论通过提交评论,您同意遵守我们的条款和社区指南。。